Investigating the impact of metformin on severity of COVID-19 in patients with Type 2 diabetes mellitus: Focusing on laboratory findings
Description
CONCLUSION: Our result suggested that metformin might be associated with better outcomes in diabetic patients infected with SARS-CoV-2.
